Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-02 05:43:51 - browse：6138

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： eGenesis tests gene

entertainment

hotspot

WSS

App could help diagnose ear infections more accurately — and at home

Biotech venture capitalists face new demands from investors

Stop the failed accountable care organization experiment

Plastic surgeons increase patient psychiatric screenings

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

eGenesis tests gene

explore

Wikipedia

hotspot

In age of alternative facts, a scholarly course on calling out crap

Intermittent fasting comes with a heart risk? Not so fast

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare Advantage today, explained in one chart

Sports medicine is finally prioritizing gender equality

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Supreme Court strikes down use of affirmative action

Research misconduct: Proposed new rules face resistance

The cancer drug shortage isn’t new — and neither are the solutions

Gene editing the human germline: What are the risks?

knowledge

The tragedy of Johnson & Johnson’s Covid vaccine

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Dewpoint Therapeutics lays off staff after losing partnerships

How digital therapeutics firms are pivoting after Pear's bankruptcy

Orchard's therapy for neuron disease in children wins FDA approval

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

focus

entertainment

hotspot

leisure time